Shows the cost savings derived from the use of the novel dosage regimen
| PAGE (gestational postnatal age, weeks) | Patients(n) | Average Weight (kg) | Total dose administered (mg) | Total theoretical dose as defined by SPC (mg) | Cost savings (mg) | Cost savings (€) | Average patient savings (€) |
|---|---|---|---|---|---|---|---|
| <40 | 18 | 4,3 | 4270,9 | 4480,6 | 209,7 | 1.514,39 € | 84,13 € |
| 40–65 | 13 | 6,4 | 4479,4 | 5060,6 | 581,2 | 4.197,21 € | 322,86 € |
| >65 | 16 | 9,5 | 5897,5 | 8119,1 | 2221,6 | 16.044,26 € | 1.002,77 € |
| Total | 47 | 6,5 | 14647,8 | 17660,2 | 3012,5 | 21755,85 € | 462,89 € |